Active Pharmaceutical Ingredients (APIs) Market Size Expected to Reach USD 344.91 Billion by 2032 [Yahoo! Finance]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Yahoo! Finance
Ottawa, June 20, 2024 (GLOBE NEWSWIRE) -- The global active pharmaceutical ingredients (APIs) market size is predicted to increase from USD 193.12 billion in 2023 to approximately USD 344.91 billion by 2032, according to a study published by Towards Healthcare a sister firm of Precedence Statistics. Download the sample version of the Active Pharmaceutical Ingredients (APIs) Market report structure and future overview in detail @ Get Sample Report Here Key takeaways North America has held the largest share in 2023. Asia Pacific region is poised for rapid growth in 2023. By type of synthesis, the synthetic segments exhibited the largest market share of around 55.84% in 2022. By application, the oncology segment is projected to be the fastest growing segment with around 7.62% CAGR from 2023-2032. Active Pharmaceutical Ingredients (APIs) Market at a Glance Active pharmaceutical ingredients are the essential components in medications that make them work. They are the chemi
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Dr. Reddy's to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business [Yahoo! Finance]Yahoo! Finance
- Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare BusinessBusiness Wire
- Haleon to sell overseas nicotine therapy business to Dr. Reddy's [Seeking Alpha]Seeking Alpha
- Global Lenalidomide Drug Market Size To Worth USD 21.47 Billion By 2033 | CAGR Of 5.69% [Yahoo! Finance]Yahoo! Finance
- Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 [Yahoo! Finance]Yahoo! Finance
RDY
Earnings
- 5/8/24 - Beat
RDY
Sec Filings
- 6/28/24 - Form 6-K
- 6/28/24 - Form 6-K
- 6/26/24 - Form 6-K
- RDY's page on the SEC website